Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Weight loss drugs are priced substantially higher in the U.S. than in other countries, analysis says
Tags Biotechnology Business News US: News
From CNBC.com News
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
Tags Business News Biotechnology US: News
From CNBC.com News
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
Tags Novo Nordisk A/S Deals & IPOs Biotech and Pharmaceuticals
From CNBC.com News
Wegovy-maker Novo Nordisk sales soar 30% on strong demand for its weight-loss drug
Tags Health care industry Novo Nordisk A/S Earnings
From CNBC.com News
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
Tags Pharmaceuticals Health Insurance Health care industry
From CNBC.com News
Obesity drug Wegovy's landmark trial result could 'open up' health insurance access, analyst says
Tags Pharmaceuticals Health care industry US: News
From CNBC.com News
Stocks making the biggest moves midday: Beyond Meat, Chegg, PNC Financial, Dish & more
Tags Novo Nordisk A/S Beyond Meat Inc Organon & Co
From CNBC.com News
Stocks making the biggest moves premarket: UPS, Lucid, Beyond Meat, Novo Nordisk and more
Tags Breaking News: Markets Sagimet Biosciences Inc Hims & Hers Health Inc
From CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
Tags Novo Nordisk A/S Science Clinical trials
From CNBC.com News
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks
Tags Eli Lilly and Co Business Europe News
From CNBC.com News
Weight loss drug Wegovy is from Europe — but users in the region face a long and costly wait
Tags Health care industry Pharmaceuticals Drugs
From CNBC.com News
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
Tags Health & Science Eli Lilly and Co Business
From CNBC.com News
Uninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says
Tags Business News Biotechnology US: News
From CNBC.com News
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
Tags US: News Biotechnology Business News
From CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
Tags Companies Pharmaceuticals Health care industry
From CNBC.com News
Stocks making the biggest moves midday: Shutterstock, Newell Brands, Zillow and more
Tags Newell Brands Inc stocks Economy
From CNBC.com News
European regulator to review weight-loss drugs following reports of suicidal thoughts
Tags Business News Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Moderna strikes deal to develop mRNA drugs in China
Tags Foreign policy Pfizer Inc Pharmaceuticals
From CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
Tags Business Eli Lilly and Co Health & Science
From CNBC.com News
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
Tags Health & Science Business Eli Lilly and Co
From CNBC.com News
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
Tags Health & Science Eli Lilly and Co Business
From CNBC.com News
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
Tags Novo Nordisk A/S Science Weight management
From CNBC.com News
Pfizer to end development of experimental obesity pill due to elevated liver enzymes
Tags Biotech and Pharmaceuticals Weight management Breaking news
From CNBC.com News
Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy
Tickers LAW LAWS
Tags Business News Law and Regulation Laws
From CNBC.com News
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Science
From CNBC.com News
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
Tags Medication Health care industry Companies
From CNBC.com News
Novo Nordisk cuts some U.S. supply of Wegovy obesity drug as demand soars
Tags Drugs Biotech and Pharmaceuticals Business News
From CNBC.com News
Obesity drug industry could be worth $200 billion within the decade, says Barclays, as market valuations grow
Tags Biotech and Pharmaceuticals Biotechnology Novo Nordisk A/S
From CNBC.com News
Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds
Tags Policy Biotech and Pharmaceuticals US Economy
From CNBC.com News
Eli Lilly, Novo Nordisk and Sanofi CEOs to testify before Senate on lowering insulin prices
Tags Diabetes Biotechnology CVS Health Corp
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.